Concepedia

Vivek Anand

VA

Statistics

Publications

13

Citations

462

H-Index

12

Active since

2010

Affiliations

All India Institute of Medical Sciences(Current)

Baylor College of Medicine

All India Institute of Medical Sciences Bhopal

The University of Texas MD Anderson Cancer Center

Vanderbilt University

Vivek Anand is an author at All India Institute of Medical Sciences specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2010–2021

13

Publications

13

Feasibility of MicroRNAs as Biomarkers for Barrett's Esophagus Progression: A Pilot Cross-Sectional, Phase 2 Biomarker Study

Ajay Bansal, In‐Hee Lee, Xiaoman Hong et al. · The American Journal of Gastroenterology · 2011 · 79 citations

, , +17

Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris

R Asothai, Vivek Anand, Dayasagar Das et al. · Immunobiology · 2015 · 61 citations

, , +17

Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2<sup>+</sup> breast cancer stem-like cells

Stanley Ly, Vivek Anand, Fouad El-Dana et al. · Journal for ImmunoTherapy of Cancer · 2021 · 51 citations · Full text

, , +17

CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach

Vivek Anand, Madhuram Khandelwal, Sandeep Appunni et al. · Journal of Cancer Research and Clinical Oncology · 2019 · 42 citations · Full text

, , +8

Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder

Sandeep Appunni, Vivek Anand, Madhuram Khandelwal et al. · Tumor Biology · 2017 · 41 citations · Full text

, , +17

1–5 of 13